May 02, 2022 / 02:00PM GMT
Michael Pollard - Bloom Burton & Co. - Managing Director
Okay. Our next company this morning is HLS Therapeutics. And we have the CEO, Gilbert Godin, to present the story. Thank you.
Gilbert Godin - HLS Therapeutics Inc. - CEO
Good morning, everyone. Thank you, Michael. Thank you to Brian, Jolyon, and the team at Bloom Burton for getting us all together again. We are very happy to take part in the annual conference. And welcome to all of you in attendance today.
Over the next 15 minutes or so, I will provide general overview of HLS before proceeding with questions. Might break here and there also for questions after certain themes.
HLS is an operating commercial-stage profitable pharma company. We were profitable from day 1 when we launched our company. We are operating in the US and in Canada. We focus on cardiovascular diseases, CNS specialties. And within those segments, we treat chronic conditions with essential medications, which brings stability and resilience to our revenue.
In six years, since we launched HLS, we built a
HLS Therapeutics Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
May 02, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers